Carmen Andreu-Oller

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “CXCR2 inhibition enables NASH-HCC immunotherapy”.

CXCR2 inhibition enables NASH-HCC immunotherapy

Gut(2022)10.1136/gutjnl-2021-326259

N/A

4.8DataRank · unranked

230 citations

John B. G. Mackey, Thomas Jamieson, Erik Ramon‐Gil, Thomas M. Drake, Frédéric Fercoq +41 more

Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis

Journal of Hepatology(2021)10.1016/j.jhep.2021.04.049

N/A

0DataRank · unranked

234 citations

Sara Torrecilla, Huan Wang, Carla Montironi, Marta Piqué‐Gili, Miguel Torres‐Martín +30 more

CXCR2 inhibition enables NASH-HCC immunotherapy

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.02.24.481779

N/A

0DataRank · unranked

3 citations

John B. G. Mackey, Thomas Jamieson, Erik Ramon‐Gil, Thomas M. Drake, Frédéric Fercoq +41 more

Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma

Molecular Cancer Therapeutics(2023)10.1158/1535-7163.mct-22-0335

N/A

0DataRank · unranked

15 citations

Laura Torrens, Carmen Andreu-Oller, Juan Carrillo-Reixach, Alexander Rialdi, Ugne Balaseviciute +24 more

Oncogenic role of PMEPA1 and its association with immune exhaustion and TGF-β activation in HCC

JHEP Reports(2024)10.1016/j.jhepr.2024.101212

N/A

0DataRank · unranked

5 citations

Carmen Andreu-Oller, Agavni Mesropian, Roger Esteban-Fabró, Marina Bárcena‐Varela, Marina Ruiz de Galarreta +19 more